Stock BIOX BIOCERES CROP SOLUTIONS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioceres Crop Solutions Corp.

Equities

BIOX

KYG1117K1141

Agricultural Chemicals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
12.05 USD -0.25% Intraday chart for Bioceres Crop Solutions Corp. -0.58% -12.24%
Feb. 08 Transcript : Bioceres Crop Solutions Corp., Q2 2024 Earnings Call, Feb 08, 2024
Feb. 08 Bioceres Crop Solutions Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 191.4 218.9 567.2 565.2 839.3 757.1 - -
Enterprise Value (EV) 1 191.4 218.9 567.2 565.2 839.3 757.1 953.9 757.1
P/E ratio - - - -80.6 x 45 x 29.6 x 10.5 x 6.93 x
Yield - - - - - - - -
Capitalization / Revenue 1.19 x 1.26 x 2.71 x 1.69 x 2 x 1.54 x 1.27 x 0.97 x
EV / Revenue 1.19 x 1.26 x 2.71 x 1.69 x 2 x 1.54 x 1.27 x 0.97 x
EV / EBITDA - 4.71 x 11.7 x 11 x 10.3 x 8.11 x 5.82 x -
EV / FCF - - -39.1 x -26.9 x -95.7 x 12.3 x 6.93 x -
FCF Yield - - -2.56% -3.71% -1.05% 8.15% 14.4% -
Price to Book - - - - 2.91 x 2.11 x 1.51 x -
Nbr of stocks (in thousands) 36,121 36,121 40,371 41,228 62,821 62,828 - -
Reference price 2 5.300 6.060 14.05 13.71 13.36 12.05 12.05 12.05
Announcement Date 9/13/19 9/10/20 9/9/21 9/8/22 9/11/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 160.6 173.1 209.5 334.8 419.8 492.4 598.3 781.1
EBITDA 1 - 46.5 48.3 51.5 81.1 93.36 130 -
EBIT 1 - 39.15 38.33 39.93 54.1 72.29 112.3 177
Operating Margin - 22.62% 18.29% 11.93% 12.89% 14.68% 18.77% 22.66%
Earnings before Tax (EBT) 1 - - - 13.98 18.8 46.4 98.38 168.9
Net income 1 - - - -7.332 16.7 26.24 75.1 114.6
Net margin - - - -2.19% 3.98% 5.33% 12.55% 14.67%
EPS 2 - - - -0.1702 0.2972 0.4067 1.147 1.740
Free Cash Flow 1 - - -14.52 -20.97 -8.772 61.7 109.3 -
FCF margin - - -6.93% -6.26% -2.09% 12.53% 18.27% -
FCF Conversion (EBITDA) - - - - - 66.09% 84.06% -
FCF Conversion (Net income) - - - - - 235.16% 145.54% -
Dividend per Share - - - - - - - -
Announcement Date 9/13/19 9/10/20 9/9/21 9/8/22 9/11/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 66.91 92.66 69.48 105.7 127.1 94.41 93.61 104.7 116.6 140.3 98.5 137.1 120 165 115
EBITDA 1 12.4 19.7 4.8 14.6 24.5 10.3 35.8 10.4 16.3 24.1 23 29.98 - - -
EBIT 1 10.05 17.7 2.147 10.04 16.99 2.219 29.87 5 5.3 16.8 19.09 28.08 - - -
Operating Margin 15.03% 19.1% 3.09% 9.5% 13.37% 2.35% 31.91% 4.78% 4.55% 11.97% 19.38% 20.48% - - -
Earnings before Tax (EBT) 1 - 9.48 -2.637 2.273 8.666 -7.745 22.29 -4.6 -2.2 9.6 13.75 22.83 - - -
Net income 1 - 3.427 -6.487 -5.147 0.4983 -8.662 28.15 -3.8 -4.6 0.1 11.24 19.09 - - -
Net margin - 3.7% -9.34% -4.87% 0.39% -9.18% 30.07% -3.63% -3.95% 0.07% 11.41% 13.92% - - -
EPS 2 - 0.0808 -0.1577 -0.1171 0.008100 -0.1381 0.4462 -0.0611 -0.0732 0.001560 0.1800 0.3000 0.0800 0.3400 0.0800
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/10/21 2/10/22 5/12/22 9/8/22 11/10/22 2/9/23 5/10/23 9/11/23 11/13/23 2/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - 197 -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - 1.514 x -
Free Cash Flow 1 - - -14.5 -21 -8.77 61.7 109 -
ROE (net income / shareholders' equity) - - - - 7.84% - 2.1% -
ROA (Net income/ Total Assets) - - - - 2.5% 6.9% 15.5% -
Assets 1 - - - - 668.1 380.3 484.5 -
Book Value Per Share 2 - - - - 4.590 5.720 7.990 -
Cash Flow per Share - - - - - - - -
Capex 1 - - 2.81 3.46 11.4 8.5 4 4
Capex / Sales - - 1.34% 1.03% 2.71% 1.73% 0.67% 0.51%
Announcement Date 9/13/19 9/10/20 9/9/21 9/8/22 9/11/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Bioceres Crop Solutions Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.05 USD
Average target price
20.25 USD
Spread / Average Target
+68.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Agricultural Chemicals

1st Jan change Capi.
BIOCERES CROP SOLUTIONS CORP. Stock Bioceres Crop Solutions Corp.
-12.24% 757M
PHOSAGRO Stock PhosAgro
-.--% 11.15B
FMC CORPORATION Stock FMC Corporation
-7.28% 7.3B
PI INDUSTRIES LIMITED Stock PI Industries Limited
+7.47% 6.87B
ICL GROUP LTD Stock ICL Group Ltd
-3.91% 5.91B
OCI N.V. Stock OCI N.V.
-6.14% 5.54B
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED Stock The Fertilisers and Chemicals Travancore Limited
-10.44% 5.6B
YUNNAN YUNTIANHUA CO., LTD. Stock Yunnan Yuntianhua Co., Ltd.
+31.35% 5.19B
UPL LIMITED Stock UPL Limited
-13.45% 4.58B
JORDAN PHOSPHATE MINES CO. PLC Stock Jordan Phosphate Mines Co. Plc
+17.77% 4.4B
Other Agricultural Chemicals
  1. Stock Market
  2. Equities
  3. BIOX Stock
  4. Financials Bioceres Crop Solutions Corp.